Dr Elena Crisà/touchhaematology.com
Oct 19, 2025, 11:27
Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
TMC (Touch Medical Communications) shared a post on LinkedIn:
“Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
In this inspiring interview, Dr Elena Crisà (Candiolo Cancer Institute, Italy) discusses how precision medicine is transforming the diagnosis and treatment of acute myeloid leukaemia ( AML ).
From clinical trials to patient-centred care, Dr Crisà shares what drives her work and why aligning treatment with individual values is essential.”
Read the full feature here.
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies